Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB, Abbvie, Acceleron, Alnylam, Altimmune, Azurrx, Bioxcel, Celon, Celsion, Hanx, Kedrion, Leap, Newron, Onconova, Passage, Pfizer, Relmada, Revance, Springworks, Synaptogenix, Synthetic, Yingli.